On May 14, 2014, the Compensation Committee and Board of Directors of Galectin Therapeutics Inc. (the “Company) increased the annual salary of Peter G. Traber, M.D., the Company’s President, Chief Executive Officer and Chief Medical Officer, to $485,000, effective immediately. The salary increase for Dr. Traber was based upon exceptional performance and a review by the Compensation Committee of comparable salary data information of similar companies.
Where did you get "over a million?"
News 
Market Data 
Discover 
